| Structure |
Chemical Name |
CAS |
MF |
 |
N-ForMyl Oxcarbazepine |
1346601-76-0 |
C16H12N2O3 |
 |
1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane 1-oxide) |
|
C28H54N8O2 |
![2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol](/CAS/20150408/GIF/848814-27-7.gif) |
2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol |
848814-27-7 |
C21H27N3O3S |
 |
(R)-Ethyl 3-(bromomethyl)hexanoate |
1956435-91-8 |
C9H17BrO2 |
![8-クロロ-11-(ピペリジン-4-イリデン)-11H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン](/CAS/20150408/GIF/117811-20-8.gif) |
8-クロロ-11-(ピペリジン-4-イリデン)-11H-ベンゾ[5,6]シクロヘプタ[1,2-B]ピリジン |
117811-20-8 |
C19H17ClN2 |
 |
Solifenacin impurity 23 |
2753060-21-6 |
|
 |
7S-Cefdinir |
178601-89-3 |
C14H13N5O5S2 |
 |
Moxifloxacin EP Impurity K |
|
|
 |
5-(3,5-ジメトキシ-4-エトキシベンジル)-2,4-ピリミジンジアミン |
78025-68-0 |
C15H20N4O3 |
 |
5-(オキシラニルメトキシ)-2,3,4,9-テトラヒドロカルバゾール |
58457-32-2 |
C15H17NO2 |
 |
Moxifloxacin Impurities |
|
|
 |
itraconazole impurity f |
|
|
 |
4-amino-1-((2R,3R,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one |
160552-54-5 |
C8H11N3O4S |
 |
cefaclor iMpurity H |
|
C4H6N4O3S2 |
 |
2-フェノキシ-4-ニトロフェノール |
70995-08-3 |
C12H9NO4 |
 |
Ribavirin IMpurity E |
58151-90-9 |
C15H16N4O6 |
 |
Mouse Neonatal Thyroxine,NN-T4 ELISA Kit |
|
|
 |
EzetiMibe ring-opening dehydrate iMpurity |
1292292-63-7 |
C24H21F2NO3 |
 |
2,3-ジクロロ-5,6-ジフェニルピラジン |
57038-62-7 |
C16H10Cl2N2 |
 |
Dapagliflozin Impurity G |
|
|
 |
Sugammadex sodium Decomposition process Impurity 3 |
|
|
 |
(E)-N-(2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl)acetamide |
178677-39-9 |
C15H19NO2 |
 |
PraMipexole IMpurity Z1/Z2 |
|
|
 |
Istradefylline Impurity E |
|
|
 |
Lercanidipine Impurity 6 |
786625-22-7 |
C37H43N3O6 |
 |
Avatrapa impurity 12 |
570403-04-2 |
C23H24Cl3N5OS2 |
![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-, hydrochloride (1:)](/CAS/20211123/GIF/570403-05-3.gif) |
3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-, hydrochloride (1:) |
570403-05-3 |
C23H26Cl3N5O2S2 |
 |
Clindamycin impurity |
198080-64-7 |
C18H32N2O5S |
 |
Olodaterol Impurity 30 |
|
|
 |
Atorvastatin Impurity 22 |
1821498-27-4 |
C27H30FNO6 |
 |
Sitagliptin Impurity 21 |
2088771-60-0 |
C20H19F6N5O5 |
![アトルバスタチン関連化合物B (3S,5R ISOMER, OR (3S,5R)-7-[3-(フェニルカルバモイル)-5-(4-フルオロフェニル)-2-イソプロピル-4-フェニル-1H-ピロール-1-イル]-3,5-ジヒドロキシヘプタン酸カ](/CAS/GIF/887196-25-0.gif) |
アトルバスタチン関連化合物B (3S,5R ISOMER, OR (3S,5R)-7-[3-(フェニルカルバモイル)-5-(4-フルオロフェニル)-2-イソプロピル-4-フェニル-1H-ピロール-1-イル]-3,5-ジヒドロキシヘプタン酸カ |
887196-25-0 |
C33H34CaFN2O5+ |
![1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride](/CAS/20200401/GIF/2252446-70-9.gif) |
1-cyclopropyl-8-ethoxy-6-fluoro-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
|
2252446-70-9 |
C22H27ClFN3O4 |
![1-((2R,3R)-3-(2,3-dihydrobenzo[b]](/CAS/20210111/GIF/2137145-62-9.gif) |
1-((2R,3R)-3-(2,3-dihydrobenzo[b] |
2137145-62-9 |
C23H36N2O5 |
 |
ジ-ノルブデソニド(MIXTURE OF DIASTEREOMERS) |
1040085-98-0 |
C23H30O6 |
 |
Brexpiprazole Impurity E |
|
|
 |
Doxofylline Impurity 7 |
43135-57-5 |
C13H20N4O4 |
 |
Pramipexole Impurity M |
|
|
 |
Brexpiprazole Impurity 20 |
105685-34-5 |
C12H14N2O |
 |
(S)-1-(2-Aminoacetyl)-pyrrolidine-2-carbonitrile |
914070-99-8 |
C7H11N3O |
 |
Empagliflozin Impurity 59 |
|
|
 |
Ticagrelor Impurity 40 |
|
|
 |
Oseltamivir Impurity 50 |
651324-06-0 |
C24H42N2O3 |
 |
Sitagliptin Defuoro IMpurity 5 |
486460-31-5 |
C16H16F5N5O |
![4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate](/CAS/20180601/GIF/65141-48-2.gif) |
4-Pyridinecarboxamide, N-[2-(nitrooxy)ethyl]-, mononitrate |
65141-48-2 |
C8H10N4O7 |
 |
Imimidistine impurity E |
|
|
 |
Ambroxol Impurity 9 HCl |
|
|
 |
Furosemide Impurity 7 |
4753-68-8 |
C5H8ClNO |
 |
Doxofylline Impurity A |
|
|
 |
Pemetrexed disodium Impurity |
17405-00-4 |
C7H5ClN2O2 |
 |
4,6-ジブロモ-3-メチルフェノール |
13321-76-1 |
C7H6Br2O |
 |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
 |
Valsartan Impurity 5 |
1266616-11-8 |
C18H21N5 |
 |
Ethacridine Impurity 10 |
20304-71-6 |
C21H16N2O4 |
 |
Pitavastatin Impurity 27 |
|
|
 |
Regorafenib Impurity 28 |
|
|
 |
Ibrutinib Impurity 6 |
1917333-91-5 |
C28H26N6O3 |
 |
Edoxaban Impurity 11 |
|
|
 |
Arbidol Impurity 27 |
|
|
 |
Olopatadine Isopropyl ester Hydrochloride |
1206456-44-1 |
C24H29NO3 |
 |
4-ヒドロキシプロポホール |
1988-10-9 |
C12H18O2 |
 |
Milrinone Impurity 5 |
|
|
 |
Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, MonoMethyl ester |
3333-46-8 |
C5H8O6 |
![(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid](/CAS2/GIF/254452-86-3.gif) |
(3S,5R,6E)-7-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-6-heptenoic acid |
254452-86-3 |
C25H24FNO4 |
 |
Regorafenib Impurity 31 |
|
|
 |
Azacitidine Impurity 1 |
|
|
 |
Empagliflozin Impurity 35 |
1459754-40-5 |
C13H8ClIO2 |
 |
Febuxostat Impurity 85 |
|
|
 |
(R)-2-(2-(tert-butoxy)-2-oxoethyl)pentanoic acid |
112106-16-8 |
C11H20O4 |
 |
Nicergoline IMp. C (EP) |
|
|
 |
Oseltamivir Impurity 67 |
|
|
 |
Linagliptin Impurity B |
|
|
 |
2A,3A,16A,17A-ジエポキシ-17B-アセトキシ-5A-アンドロスタン |
50588-22-2 |
C21H30O4 |
 |
Trimetazidine Impurity 16 |
118709-62-9 |
C13H16O4 |
 |
Bosutinib Impurity 37 |
2095306-27-5 |
C39H30Cl4N6O6 |
 |
1,2-Benzenedicarboxylic acid, 3-amino-, 2-ethyl ester |
1822756-03-5 |
C10H11NO4 |
 |
Traxipide impurity |
|
|
![(S)-1-[(4-クロロフェニル)フェニルメチル]ピペラジン](/CAS/GIF/439858-21-6.gif) |
(S)-1-[(4-クロロフェニル)フェニルメチル]ピペラジン |
439858-21-6 |
C17H19ClN2 |
 |
Medetomidine Impurity 14 |
79924-14-4 |
C13H16N2 |
 |
Cefotiam Impurity D |
|
|
 |
Formoterol O-β-D-Glucuronide |
615551-59-2 |
C25H32N2O10 |
 |
Palbociclib Impurity 66 |
|
|
 |
Sitafloxacin Impurity 4 |
|
|
 |
(E)-5-(2-カルボキシビニル)-2'-デオキシウリジン |
74131-06-9 |
C12H14N2O7 |
 |
Ropivacaine-ET-R |
98626-60-9 |
C16H24N2O |
 |
Pramipexole Related Impurity 3 |
2166216-34-6 |
C10H17N3OS |
 |
Dolutegravir Impurity C |
1802141-49-6 |
C22H23F2N3O5 |
 |
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
 |
1-(3-Cyanopyridyl-2)-2-Phenyl-4-Methylpyperazine |
61337-88-0 |
C17H18N4 |
 |
Fingolimod EP Impurity D |
780729-32-0 |
C21H37NO2 |
 |
Bortezomib Impurity P |
|
|
 |
N-(3-(4-(3-ピリジル)ピリミジン-2-イルアミノ)-4-メチルフェニル)-4-クロロメチルベンズアミド |
404844-11-7 |
C24H20ClN5O |
 |
(2R,3R,4R,5S)-6-((2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)phenyl)amino)hexane-1,2,3,4,5-pentaol |
|
|
 |
2-(3-メトキシフェノキシ)エタンアミン |
6487-86-1 |
C9H13NO2 |
 |
Avermectin A1a, 25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-α-L-arabino-hexopyranosyl)-5-demethoxy-25-de(1-methylpropyl)-22,23-dihydro-23-hydroxy-5-(hydroxyimino)-, (23S)- (9CI) |
165108-08-7 |
C43H63NO12 |
 |
1-(4-methylbenzyl)-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |
|
|
![4-[2-ヒドロキシ-3-[(1-メチルエチル)アミノ]プロポキシ]ベンゼンプロパン酸](/CAS/GIF/81148-15-4.gif) |
4-[2-ヒドロキシ-3-[(1-メチルエチル)アミノ]プロポキシ]ベンゼンプロパン酸 |
81148-15-4 |
C15H23NO4 |
![L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]-](/CAS/20200401/GIF/290298-02-1.gif) |
L-Leucine, N-[(2S)-2-amino-1-oxo-4-phenylbutyl]- |
290298-02-1 |
C16H24N2O3 |
 |
Miglitol Isomer ImpurityA |
|
|
 |
sodium 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-3-hydroxypropanoate |
|
|